• REGENCY: Obinutuzumab’s Promise for Lupus Nephritis

  • Feb 28 2025
  • Duración: 54 m
  • Podcast

REGENCY: Obinutuzumab’s Promise for Lupus Nephritis

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • Join Dr Raquel Faria and Professors Richard Furie and Maria Dall’Era as they discuss the results of the phase 3 REGENCY trial of obinutuzumab for the treatment of lupus nephritis.This episode explores what obinutuzumab could mean for the future management of lupus nephritis.

    Disclaimer: During Lupus Academy podcast episodes, participants may refer to off label use of medicines forpatients with lupus. Lupus Academy does not make any recommendations about using a medicine outside the terms of its approved licence for use.
    Más Menos
Más Menos
adbl_web_global_use_to_activate_webcro805_stickypopup

Lo que los oyentes dicen sobre REGENCY: Obinutuzumab’s Promise for Lupus Nephritis

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles